ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vector Development and Manufacturing Services Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-32M18945
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vector Development and Manufacturing Services Market Research Report 2025
BUY CHAPTERS

Global Viral Vector Development and Manufacturing Services Market Research Report 2025

Code: QYRE-Auto-32M18945
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
AGC Biologics
Wuxi Biologics
Merck
Charles River
Lonza
Aldevron
Curia
Idt Biologika
Danaher Life Sciences
Exothera
SK pharmteco
Ubrigene
Revvity

Viral Vector Development and Manufacturing Services Market Size

The global market for Viral Vector Development and Manufacturing Services was valued at US$ 4126 million in the year 2024 and is projected to reach a revised size of US$ 6821 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Viral Vector Development and Manufacturing Services Market

Viral Vector Development and Manufacturing Services Market

Viral vector development and manufacturing services refers to services focused on the R&D, production and manufacturing process optimization of viral vectors. These services usually cover the entire process from viral vector design, construction, production, purification to quality control, aiming to provide customers with efficient, safe and scalable viral vector products to meet the needs of biopharmaceutical fields such as gene therapy and cell therapy.
North American market for Viral Vector Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Vector Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Viral Vector Development and Manufacturing Services in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Viral Vector Development and Manufacturing Services include Thermo Fisher Scientific, AGC Biologics, WuXi Biologics, Merck, Charles River, Lonza, Aldevron, Curia, IDT Biologika, Danaher Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Development and Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Development and Manufacturing Services.
The Viral Vector Development and Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Development and Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Development and Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Vector Development and Manufacturing Services Market Report

Report Metric Details
Report Name Viral Vector Development and Manufacturing Services Market
Accounted market size in year US$ 4126 million
Forecasted market size in 2031 US$ 6821 million
CAGR 8.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, AGC Biologics, WuXi Biologics, Merck, Charles River, Lonza, Aldevron, Curia, IDT Biologika, Danaher Life Sciences, Exothera, SK pharmteco, ubrigene, Revvity
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vector Development and Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Development and Manufacturing Services Market growing?

Ans: The Viral Vector Development and Manufacturing Services Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Viral Vector Development and Manufacturing Services Market size in 2031?

Ans: The Viral Vector Development and Manufacturing Services Market size in 2031 will be US$ 6821 million.

Who are the main players in the Viral Vector Development and Manufacturing Services Market report?

Ans: The main players in the Viral Vector Development and Manufacturing Services Market are Thermo Fisher Scientific, AGC Biologics, WuXi Biologics, Merck, Charles River, Lonza, Aldevron, Curia, IDT Biologika, Danaher Life Sciences, Exothera, SK pharmteco, ubrigene, Revvity

What are the Application segmentation covered in the Viral Vector Development and Manufacturing Services Market report?

Ans: The Applications covered in the Viral Vector Development and Manufacturing Services Market report are Gene Therapy, Cell Therapy, Vaccine Development, Others

What are the Type segmentation covered in the Viral Vector Development and Manufacturing Services Market report?

Ans: The Types covered in the Viral Vector Development and Manufacturing Services Market report are Adenoviral Vectors, Adeno-Associated Viral (AAV) Vectors, Lentiviral Vectors, Retroviral Vectors, Others

Recommended Reports

Gene & Cell Therapy

Viral Vector Markets

Vaccine & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development and Manufacturing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adenoviral Vectors
1.2.3 Adeno-Associated Viral (AAV) Vectors
1.2.4 Lentiviral Vectors
1.2.5 Retroviral Vectors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Viral Vector Development and Manufacturing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Cell Therapy
1.3.4 Vaccine Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Development and Manufacturing Services Market Perspective (2020-2031)
2.2 Global Viral Vector Development and Manufacturing Services Growth Trends by Region
2.2.1 Global Viral Vector Development and Manufacturing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Development and Manufacturing Services Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Development and Manufacturing Services Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Development and Manufacturing Services Market Dynamics
2.3.1 Viral Vector Development and Manufacturing Services Industry Trends
2.3.2 Viral Vector Development and Manufacturing Services Market Drivers
2.3.3 Viral Vector Development and Manufacturing Services Market Challenges
2.3.4 Viral Vector Development and Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Development and Manufacturing Services Players by Revenue
3.1.1 Global Top Viral Vector Development and Manufacturing Services Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Development and Manufacturing Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Viral Vector Development and Manufacturing Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Development and Manufacturing Services Revenue
3.4 Global Viral Vector Development and Manufacturing Services Market Concentration Ratio
3.4.1 Global Viral Vector Development and Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development and Manufacturing Services Revenue in 2024
3.5 Global Key Players of Viral Vector Development and Manufacturing Services Head office and Area Served
3.6 Global Key Players of Viral Vector Development and Manufacturing Services, Product and Application
3.7 Global Key Players of Viral Vector Development and Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Development and Manufacturing Services Breakdown Data by Type
4.1 Global Viral Vector Development and Manufacturing Services Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Development and Manufacturing Services Forecasted Market Size by Type (2026-2031)
5 Viral Vector Development and Manufacturing Services Breakdown Data by Application
5.1 Global Viral Vector Development and Manufacturing Services Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Development and Manufacturing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Development and Manufacturing Services Market Size (2020-2031)
6.2 North America Viral Vector Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025)
6.4 North America Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Development and Manufacturing Services Market Size (2020-2031)
7.2 Europe Viral Vector Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025)
7.4 Europe Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Development and Manufacturing Services Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Development and Manufacturing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Development and Manufacturing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Development and Manufacturing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Development and Manufacturing Services Market Size (2020-2031)
9.2 Latin America Viral Vector Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Development and Manufacturing Services Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral Vector Development and Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Viral Vector Development and Manufacturing Services Introduction
11.2.4 AGC Biologics Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.2.5 AGC Biologics Recent Development
11.3 WuXi Biologics
11.3.1 WuXi Biologics Company Details
11.3.2 WuXi Biologics Business Overview
11.3.3 WuXi Biologics Viral Vector Development and Manufacturing Services Introduction
11.3.4 WuXi Biologics Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.3.5 WuXi Biologics Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Viral Vector Development and Manufacturing Services Introduction
11.4.4 Merck Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Viral Vector Development and Manufacturing Services Introduction
11.5.4 Charles River Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.5.5 Charles River Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Viral Vector Development and Manufacturing Services Introduction
11.6.4 Lonza Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.6.5 Lonza Recent Development
11.7 Aldevron
11.7.1 Aldevron Company Details
11.7.2 Aldevron Business Overview
11.7.3 Aldevron Viral Vector Development and Manufacturing Services Introduction
11.7.4 Aldevron Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.7.5 Aldevron Recent Development
11.8 Curia
11.8.1 Curia Company Details
11.8.2 Curia Business Overview
11.8.3 Curia Viral Vector Development and Manufacturing Services Introduction
11.8.4 Curia Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.8.5 Curia Recent Development
11.9 IDT Biologika
11.9.1 IDT Biologika Company Details
11.9.2 IDT Biologika Business Overview
11.9.3 IDT Biologika Viral Vector Development and Manufacturing Services Introduction
11.9.4 IDT Biologika Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.9.5 IDT Biologika Recent Development
11.10 Danaher Life Sciences
11.10.1 Danaher Life Sciences Company Details
11.10.2 Danaher Life Sciences Business Overview
11.10.3 Danaher Life Sciences Viral Vector Development and Manufacturing Services Introduction
11.10.4 Danaher Life Sciences Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.10.5 Danaher Life Sciences Recent Development
11.11 Exothera
11.11.1 Exothera Company Details
11.11.2 Exothera Business Overview
11.11.3 Exothera Viral Vector Development and Manufacturing Services Introduction
11.11.4 Exothera Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.11.5 Exothera Recent Development
11.12 SK pharmteco
11.12.1 SK pharmteco Company Details
11.12.2 SK pharmteco Business Overview
11.12.3 SK pharmteco Viral Vector Development and Manufacturing Services Introduction
11.12.4 SK pharmteco Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.12.5 SK pharmteco Recent Development
11.13 ubrigene
11.13.1 ubrigene Company Details
11.13.2 ubrigene Business Overview
11.13.3 ubrigene Viral Vector Development and Manufacturing Services Introduction
11.13.4 ubrigene Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.13.5 ubrigene Recent Development
11.14 Revvity
11.14.1 Revvity Company Details
11.14.2 Revvity Business Overview
11.14.3 Revvity Viral Vector Development and Manufacturing Services Introduction
11.14.4 Revvity Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025)
11.14.5 Revvity Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
AGC Biologics
Wuxi Biologics
Merck
Charles River
Lonza
Aldevron
Curia
Idt Biologika
Danaher Life Sciences
Exothera
SK pharmteco
Ubrigene
Revvity
List of Tables
 Table 1. Global Viral Vector Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adenoviral Vectors
 Table 3. Key Players of Adeno-Associated Viral (AAV) Vectors
 Table 4. Key Players of Lentiviral Vectors
 Table 5. Key Players of Retroviral Vectors
 Table 6. Key Players of Others
 Table 7. Global Viral Vector Development and Manufacturing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Viral Vector Development and Manufacturing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Viral Vector Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Viral Vector Development and Manufacturing Services Market Share by Region (2020-2025)
 Table 11. Global Viral Vector Development and Manufacturing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Viral Vector Development and Manufacturing Services Market Share by Region (2026-2031)
 Table 13. Viral Vector Development and Manufacturing Services Market Trends
 Table 14. Viral Vector Development and Manufacturing Services Market Drivers
 Table 15. Viral Vector Development and Manufacturing Services Market Challenges
 Table 16. Viral Vector Development and Manufacturing Services Market Restraints
 Table 17. Global Viral Vector Development and Manufacturing Services Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Viral Vector Development and Manufacturing Services Market Share by Players (2020-2025)
 Table 19. Global Top Viral Vector Development and Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Development and Manufacturing Services as of 2024)
 Table 20. Ranking of Global Top Viral Vector Development and Manufacturing Services Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Viral Vector Development and Manufacturing Services Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Viral Vector Development and Manufacturing Services, Headquarters and Area Served
 Table 23. Global Key Players of Viral Vector Development and Manufacturing Services, Product and Application
 Table 24. Global Key Players of Viral Vector Development and Manufacturing Services, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Viral Vector Development and Manufacturing Services Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Viral Vector Development and Manufacturing Services Revenue Market Share by Type (2020-2025)
 Table 28. Global Viral Vector Development and Manufacturing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Viral Vector Development and Manufacturing Services Revenue Market Share by Type (2026-2031)
 Table 30. Global Viral Vector Development and Manufacturing Services Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Viral Vector Development and Manufacturing Services Revenue Market Share by Application (2020-2025)
 Table 32. Global Viral Vector Development and Manufacturing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Viral Vector Development and Manufacturing Services Revenue Market Share by Application (2026-2031)
 Table 34. North America Viral Vector Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Viral Vector Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Viral Vector Development and Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Viral Vector Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Viral Vector Development and Manufacturing Services Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Viral Vector Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Viral Vector Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Viral Vector Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Viral Vector Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Thermo Fisher Scientific Company Details
 Table 50. Thermo Fisher Scientific Business Overview
 Table 51. Thermo Fisher Scientific Viral Vector Development and Manufacturing Services Product
 Table 52. Thermo Fisher Scientific Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 53. Thermo Fisher Scientific Recent Development
 Table 54. AGC Biologics Company Details
 Table 55. AGC Biologics Business Overview
 Table 56. AGC Biologics Viral Vector Development and Manufacturing Services Product
 Table 57. AGC Biologics Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 58. AGC Biologics Recent Development
 Table 59. WuXi Biologics Company Details
 Table 60. WuXi Biologics Business Overview
 Table 61. WuXi Biologics Viral Vector Development and Manufacturing Services Product
 Table 62. WuXi Biologics Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 63. WuXi Biologics Recent Development
 Table 64. Merck Company Details
 Table 65. Merck Business Overview
 Table 66. Merck Viral Vector Development and Manufacturing Services Product
 Table 67. Merck Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 68. Merck Recent Development
 Table 69. Charles River Company Details
 Table 70. Charles River Business Overview
 Table 71. Charles River Viral Vector Development and Manufacturing Services Product
 Table 72. Charles River Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 73. Charles River Recent Development
 Table 74. Lonza Company Details
 Table 75. Lonza Business Overview
 Table 76. Lonza Viral Vector Development and Manufacturing Services Product
 Table 77. Lonza Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 78. Lonza Recent Development
 Table 79. Aldevron Company Details
 Table 80. Aldevron Business Overview
 Table 81. Aldevron Viral Vector Development and Manufacturing Services Product
 Table 82. Aldevron Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 83. Aldevron Recent Development
 Table 84. Curia Company Details
 Table 85. Curia Business Overview
 Table 86. Curia Viral Vector Development and Manufacturing Services Product
 Table 87. Curia Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 88. Curia Recent Development
 Table 89. IDT Biologika Company Details
 Table 90. IDT Biologika Business Overview
 Table 91. IDT Biologika Viral Vector Development and Manufacturing Services Product
 Table 92. IDT Biologika Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 93. IDT Biologika Recent Development
 Table 94. Danaher Life Sciences Company Details
 Table 95. Danaher Life Sciences Business Overview
 Table 96. Danaher Life Sciences Viral Vector Development and Manufacturing Services Product
 Table 97. Danaher Life Sciences Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 98. Danaher Life Sciences Recent Development
 Table 99. Exothera Company Details
 Table 100. Exothera Business Overview
 Table 101. Exothera Viral Vector Development and Manufacturing Services Product
 Table 102. Exothera Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 103. Exothera Recent Development
 Table 104. SK pharmteco Company Details
 Table 105. SK pharmteco Business Overview
 Table 106. SK pharmteco Viral Vector Development and Manufacturing Services Product
 Table 107. SK pharmteco Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 108. SK pharmteco Recent Development
 Table 109. ubrigene Company Details
 Table 110. ubrigene Business Overview
 Table 111. ubrigene Viral Vector Development and Manufacturing Services Product
 Table 112. ubrigene Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 113. ubrigene Recent Development
 Table 114. Revvity Company Details
 Table 115. Revvity Business Overview
 Table 116. Revvity Viral Vector Development and Manufacturing Services Product
 Table 117. Revvity Revenue in Viral Vector Development and Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 118. Revvity Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Viral Vector Development and Manufacturing Services Picture
 Figure 2. Global Viral Vector Development and Manufacturing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Vector Development and Manufacturing Services Market Share by Type: 2024 VS 2031
 Figure 4. Adenoviral Vectors Features
 Figure 5. Adeno-Associated Viral (AAV) Vectors Features
 Figure 6. Lentiviral Vectors Features
 Figure 7. Retroviral Vectors Features
 Figure 8. Others Features
 Figure 9. Global Viral Vector Development and Manufacturing Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Viral Vector Development and Manufacturing Services Market Share by Application: 2024 VS 2031
 Figure 11. Gene Therapy Case Studies
 Figure 12. Cell Therapy Case Studies
 Figure 13. Vaccine Development Case Studies
 Figure 14. Others Case Studies
 Figure 15. Viral Vector Development and Manufacturing Services Report Years Considered
 Figure 16. Global Viral Vector Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Viral Vector Development and Manufacturing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Viral Vector Development and Manufacturing Services Market Share by Region: 2024 VS 2031
 Figure 19. Global Viral Vector Development and Manufacturing Services Market Share by Players in 2024
 Figure 20. Global Viral Vector Development and Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Viral Vector Development and Manufacturing Services Revenue in 2024
 Figure 22. North America Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Viral Vector Development and Manufacturing Services Market Share by Country (2020-2031)
 Figure 24. United States Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Viral Vector Development and Manufacturing Services Market Share by Country (2020-2031)
 Figure 28. Germany Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Viral Vector Development and Manufacturing Services Market Share by Region (2020-2031)
 Figure 36. China Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Viral Vector Development and Manufacturing Services Market Share by Country (2020-2031)
 Figure 44. Mexico Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Viral Vector Development and Manufacturing Services Market Share by Country (2020-2031)
 Figure 48. Turkey Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Viral Vector Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 52. AGC Biologics Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 53. WuXi Biologics Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 55. Charles River Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 56. Lonza Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 57. Aldevron Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 58. Curia Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 59. IDT Biologika Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 60. Danaher Life Sciences Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 61. Exothera Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 62. SK pharmteco Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 63. ubrigene Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 64. Revvity Revenue Growth Rate in Viral Vector Development and Manufacturing Services Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Viral Vector Manufacturing Services Market Research Report 2024
Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024
Viral Vector Packaging Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Research Grade Viral Vector Packaging Service Market Research Report 2025
Global Viral Vector Development Service Market Research Report 2025
Global Viral Vector Manufacturing Market Research Report 2024
Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2024
Global Viral Vector Manufacturing CDMO Services Market Research Report 2024
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025
Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024
Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Development Service Market Research Report 2025
Global Oncolytic Virus Manufacturing Services Market Research Report 2024
Global GMP Viral Vector Manufacturing Market Research Report 2024
Global Viral Vector Purification Market Research Report 2025
Global Nanomedicine Development and Manufacturing Services Market Research Report 2025
Global Gene Therapy Viral Packaging Service Market Research Report 2024
Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions